Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Convergent evolution and multi-wave clonal invasion in H3 K27-altered diffuse midline gliomas treated with a PDGFR inhibitor.
Journal: Acta neuropathologica communications
Published: March 10, 2022
Phase I study using crenolanib to target PDGFR kinase in children and young adults with newly diagnosed DIPG or recurrent high-grade glioma, including DIPG.
Journal: Neuro-oncology advances
Published: January 07, 2022
Population Pharmacokinetics of Sunitinib and its Active Metabolite SU012662 in Pediatric Patients with Gastrointestinal Stromal Tumors or Other Solid Tumors.
Journal: European journal of drug metabolism and pharmacokinetics
Published: January 22, 2021
A phase 1 study of prexasertib (LY2606368), a CHK1/2 inhibitor, in pediatric patients with recurrent or refractory solid tumors, including CNS tumors: A report from the Children's Oncology Group Pediatric Early Phase Clinical Trials Network (ADVL1515).
Journal: Pediatric blood & cancer
Published: January 17, 2021
Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma.
Journal: Nature communications
Published: June 10, 2020
Ad-CD40L mobilizes CD4 T cells for the treatment of brainstem tumors.
Journal: Neuro-oncology
Published: May 28, 2020
Population pharmacokinetics-pharmacodynamics of sunitinib in pediatric patients with solid tumors.
Journal: Cancer chemotherapy and pharmacology
Published: March 04, 2020
Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic features.
Journal: Acta neuropathologica
Published: January 09, 2020
Physiologically Based Pharmacokinetic Modeling and Simulation of Sunitinib in Pediatrics.
Journal: The AAPS journal
Published: October 24, 2019
A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumors.
Journal: Pediatric blood & cancer
Published: September 02, 2019
In vitro activity of a G-quadruplex-stabilizing small molecule that synergizes with Navitoclax to induce cytotoxicity in acute myeloid leukemia cells.
Journal: BMC cancer
Published: August 02, 2019
Last Updated: 09/26/2026